# Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users

> **NCT03657355** · PHASE1 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 63 (actual)

## Conditions studied

- Healthy Recreational Drug Users

## Interventions

- **DRUG:** ACT-541468
- **DRUG:** Suvorexant
- **DRUG:** Zolpidem
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03657355
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-07
- **Primary completion:** 2019-08-08
- **Final completion:** 2019-08-08
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03657355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03657355, "Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03657355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*